Xencor, Inc.
METHODS OF TREATING NEUROLOGICAL DISEASES
Last updated:
Abstract:
The present disclosure is directed to a method of treating neurological disorder comprising measuring c-reactive protein in a patient and peripherally administering to the patient a DN-TNF polypeptide that inhibits the activity of soluble TNF-but not transmembrane TNF-.alpha..
Status:
Application
Type:
Utility
Filling date:
1 Apr 2019
Issue date:
4 Jun 2020